Drugs / Micro V Probiotics
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03521297 | Jan 2020 → Jan 2021 | primary biliary cholangitis | Sun Yat-sen University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Micro V Probiotics | “probiotic(Micro V Probiotics)” NCT03521297 ↗ |
| Route | Oral | “Probiotics (three times per day, one pack each time) and UDCA(13-15mg/kg/day), orally, 6 months” NCT03521297 ↗ |